MS

Michael Schnall-Levin

North America, California, United States

Description

Michael Schnall-Levin is the Chief Technology Officer and Founding Scientist at 10x Genomics. Michael earned his Ph.D. in Mathematics from...

Investor Profile

Michael Schnall-Levin has made 1 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Michael Schnall-Levin frequently co-invest with?

Catapult Ventures
North America, California, United States, Los Altos
Co-Investments: 1
Vision Plus Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Caltech
North America, California, United States, Pasadena
Co-Investments: 1
MV
North America, California, United States, Manhattan Beach
Co-Investments: 1

Which angels does Michael Schnall-Levin often collaborate with?

JP
North America, California, United States, San Francisco
Shared Deals: 1
EL
North America, California, United States, San Francisco
Shared Deals: 1
Dario Amodei
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Michael Schnall-Levin?

Biostate AI

Palo Alto, California, United States

Biostate AI develops generative AI that benefit all human health.

BiotechnologyHealth Care
SeedJul 8, 2024
Amount Raised: $4,000,000